Clinical trialNCT00544960CompletedPhase 2Interventional

A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer

SponsorAscenta TherapeuticsEnrollment106Non-small Cell Lung Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Lance Leopold, MD
Ascenta Therapeutics, Inc.
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Russia

Research Site
Arkhangelsk, Russia
Research Site
Chelyabinsk, Russia
Research Site
Kaliningrad, Russia
Research Site
Kazan', Russia
Research Site
Moscow, Russia
Research Sites (4)
Saint Petersburg, Russia
Research Site
Samara, Russia
Research Site
Stavropol, Russia
Research Site
Voronezh, Russia
Research Site
Yekaterinburg, Russia

Ukraine

Research Site
Dnipropetrovsk, Ukraine
Research Site
Donetsk, Ukraine
Research Site
Kharkiv, Ukraine
Research Site
Kyiv, Ukraine
Research Site
Luhansk, Ukraine
Research Site
Uzhhorod, Ukraine
Research Site
Zaporizhzhya, Ukraine

United States

Research Site
Durham, North Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2007
Primary completion: 30 Nov 2008
Completion: 30 Apr 2009
Last update posted: 27 Aug 2010
Registered enrollment: 106
Registry id: NCT00544960

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.